Compass Therapeutics is a Boston biopharmaceutical company developing antibody drugs to treat cancer. It last closed at $0.69 on Nov 20, up 1.43% on the day. The next earnings report for CMPX is expected around Thu, Mar 4, 2027. For the quarter ended Sep 2026, CMPX reported EPS of -$0.15. Over its last 8 reports the stock moved an average of 5.8% the session after earnings. Over the last 12 months CMPX insiders bought $27K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is CMPX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CMPX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CMPXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CMPX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 8% below its 20 day and 43% below its 50 day average. It is 305% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 37), near oversold. The nearest support is the swing low (Nov 6) at $0.67, and the nearest resistance the Pivot at $0.69.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNear oversold
VolatilityHigh, 10.7%/day
Key levels
$6.8852 week high+897.1%
$2.78200 day average+302.9%
$1.60100 day average+131.9%
$0.9850 day average+42.0%
$0.81Swing high (Nov 2)+17.4%
$0.7420 day average+7.2%
$0.73Pivot R1+5.8%
$0.69Pivot+0.0%
$0.69Last close
$0.67Swing low (Nov 6)−2.9%
$0.64Pivot S1−7.2%
$0.5752 week low−17.4%
Indicators
RSI (14)
37.29
Weak, oversold below 30
Neutral
MACD
-0.09
Above its signal line
Bullish
Stochastic
27.4
Middle of its range
Neutral
ADX (14)
44.5
Strong downtrend
Williams %R
-63.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-78.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−9.3%
Change over 10 sessions
Bearish
ATR (14)
$0.07
Typical daily range, 10.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 47.5%/day
Key levels
$6.8852 week high+897.1%
$2.78200 day average+302.9%
$1.60100 day average+131.9%
$0.9850 day average+42.0%
$0.81Swing high (Nov 2)+17.4%
$0.7420 day average+7.2%
$0.73Pivot R1+5.8%
$0.69Pivot+0.0%
$0.69Last close
$0.67Swing low (Nov 6)−2.9%
$0.64Pivot S1−7.2%
$0.5752 week low−17.4%
Indicators
RSI (14)
26.62
Oversold below 30
Oversold
MACD
-0.66
Below its signal line
Bearish
Stochastic
5.4
Near the bottom of its range
Oversold
ADX (14)
34.7
Trending down
Williams %R
-94.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-96.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−65.6%
Change over 10 sessions
Bearish
ATR (14)
$0.33
Typical daily range, 47.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CMPX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CMPX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CMPX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CMPXHow many large options trades hit CMPX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CMPX in the last 90 days.
From SEC Form 4 filings by CMPX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CMPX is in one of them and how their past CMPX trades turned out.
Compass Therapeutics is a biopharmaceutical company based in Boston, Massachusetts, that develops antibody drugs for cancer. Its lead candidate, tovecimig, is designed to block two signaling pathways that tumors use to grow new blood vessels, and it is being tested in patients with biliary tract cancer. The company also has three other clinical stage candidates that target immune system pathways, including CD137 and PD-1. None of these candidates has been approved for sale.